Page 25 - JCTR-10-3
P. 25

Shegena et al. | Journal of Clinical and Translational Research 2024; 10(3): 191-200   199
        [11]  Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care   Related  Problems  and  Health  Outcomes:  A  Cross-
             Practice: The Patient-centered Approach to Medication   Sectional Study among Cardiovascular Patients. Pharm
             Management.  New  York: McGraw Hill Professional;      World Sci 2010;32:512-9.
             2012.                                                  doi: 10.1007/s11096-010-9401-1
        [12]   Pharmaceutical  Care  Network  Europe.  Classification   [23]  Basger  BJ,  Moles  RJ,  Chen  TF.  Development  of  an
             for  Drug  Related  Problems  Version  9.1.  Netherlands:   Aggregated  System  for  Classifying  Causes  of  Drug-
             Pharmaceutical Care Network Europe Association; 2020.   Related Problems. Ann Pharmacother 2015;49:405-18.
             p.  1-10.  Available  from:  https://www.pcne.org/upload/     doi: 10.1177/1060028014568008
             files/334_pcne_classification_v9-0.pdf  [Last  accessed   [24]  Maggioni AP. Epidemiology of Heart Failure in Europe.
             on 2022 Jun 11].                                       Heart Fail Clin 2015;11:625-35.
        [13]  Hohmann  C,  Eickhoff  C,  Klotz  JM,  Schulz  M,      doi: 10.1016/j.hfc.2015.07.015
             Radziwill R. Development of a Classification System for
             Drug-Related  Problems  in  the  Hospital  Setting  (APS-  [25]  Wendie TF, Angamo MT. Drug-Therapy Problems and
             Doc)  and  Assessment  of  the  Inter-Rater  Reliability.   Predictors  among  Hospitalized  Heart-Failure  Patients:
             J Clin Pharm Ther 2012;37:276-81.                      A Prospective Observational Study. Drug Healthc Patient
                                                                    Saf 2020;12:281-91.
        [14]  Flesch M, Erdmann E. The Problem of Polypharmacy in      doi: 10.2147/DHPS.S268923
             Heart Failure. Curr Cardiol Rep 2006;8(3):217-25.
        [15]  Viktil KK, Blix HS. The Impact of Clinical Pharmacists   [26]  WHO. World Health Organisation. WHO Collaborating
             on Drug-Related Problems and Clinical Outcomes. Basic   Centre for Drug Statistics Methodology; 2022. Available
             Clin Pharmacol Toxicol 2008;102:275-80.                from:   https://www.whocc.no/atc_ddd_index   [Last
                                                                    accessed on 2021 May 18].
             doi: 10.1111/j.1742-7843.2007.00206.x             [27]  Niriayo  YL,  Kumela  K,  Kassa  TD,  Angamo  MT.
        [16]  Yadesa  TM,  Kitutu  FE,  Deyno  S,  Ogwang  PE,      Drug  Therapy  Problems  and  Contributing  Factors  in
             Tamukong  R,  Alele  PE.  Prevalence,  Characteristics   the Management of Heart Failure Patients  in Jimma
             and Predicting Risk Factors of Adverse Drug Reactions   University  Specialized  Hospital,  Southwest  Ethiopia.
             among Hospitalized  Older  Adults:  A  Systematic      PLoS One 2018;13:e0206120.
             Review  and  Meta-analysis.  SAGE  Open  Med           doi: 10.1371/journal.pone.0206120
             2021;9:20503121211039099.
             doi:10.1177/20503121211039099                     [28]  Gizaw  K,  Dubale  M.  Drug  Related  Problems  and
                                                                    Contributing Factors among adult Ambulatory Patients
        [17]  Sztramko R, Chau V, Wong R. Adverse Drug Events and   with  Cardiovascular  Diseases  at  Gebretsadik  Shawo
             Associated Factors in Heart Failure Therapy among the   General Hospital, Bonga, South West Ethiopia. J Nat Sci
             Very Elderly. Can Geriatr J 2011;14:79-92.             Res 2017;7:9-16.
             doi: 10.5770/cgj.v14i4.19                         [29]  Seid E, Engidawork E,  Alebachew M, Mekonnen D,
        [18]  Rushton  CA,  Strömberg  A,  Jaarsma  T,  Kadam  UT.   Berha  AB.  Evaluation  of  Drug  Therapy  Problems,
             Multidrug and Optimal Heart Failure Therapy Prescribing   Medication  Adherence and  Treatment  Satisfaction
             in Older General Practice Populations: A Clinical Data   among Heart Failure Patients on Follow-up at a Tertiary
             Linkage Study. BMJ Open 2014;4:e003698.                Care Hospital in Ethiopia. PLoS One 2020;15:e0237781.
             doi: 10.1136/bmjopen-2013-003698                       doi: 10.1371/journal.pone.0237781
        [19]  Urbina  O,  Ferrández  O,  Luque  S,  Grau  S,  Mojal  S,   [30]  Gastelurrutia  P,  Benrimoj  SI,  Espejo  J,  Tuneu  L,
             Pellicer R, et al. Patient Risk Factors for Developing a   Mangues  MA,  Bayes-Genis  A.  Negative  Clinical
             Drug-related Problem in a Cardiology Ward. Ther Clin   Outcomes Associated with Drug-related Problems in Heart
             Risk Manag 2015;11:9-15.                               Failure  (HF)  Outpatients:  Impact  of  a  Pharmacist  in  a
             doi: 10.2147/TCRM.S71749                               Multidisciplinary HF Clinic. J Card Fail 2011;17:217-23.
        [20]  Tegegne  GT,  Yimamm  B,  Yesuf  EA.  Drug  Therapy      doi: 10.1016/j.cardfail.2010.10.009
             Problems and Contributing Factors among Patients with   [31]  Hsu  WT,  Shen  LJ,  Lee  CM.  Drug-Related  Problems
             Cardiovascular Diseases in Felege Hiwot Referral and   Vary with Medication Category and Treatment Duration
             Jimma University Specialized Hospital, Ethiopia. Indo   in Taiwanese Heart Failure Outpatients Receiving Case
             Glob J Pharm Sci 2015;5:26-39.                         Management. J Formos Med Assoc 2016;115:335-42.
             doi: 10.35652/igjps.2015.21                            doi: 10.1016/j.jfma.2015.11.014
        [21]  Shareef J, Sandeep B, Shastry CS. Assessment of Drug   [32]  Shwetha  N,  Pradhan A,  Shabaraya AR,  Niveditha TV,
             Related  Problems  in  Patients  with  Cardiovascular   Jose  C, Ambika V.  Risk  Factors  for  Developing  Drug
             Diseases in a Tertiary Care Teaching Hospital. J Pharm   Related  Problems  in  Patients  with  Cardiovascular
             Care 2014;2:70-6.                                      Diseases. Int J Res Rev 2021;8:403-9.
        [22]  Niquille  A,  Bugnon  O.  Relationship  between  Drug-  [33]  Tegegne  GT,  Yimam  B,  Yesuf  EA,  Gelaw  BK,

                                              DOI: https://doi.org/10.36922/jctr.23.00137
   20   21   22   23   24   25   26   27   28   29   30